MedTrace Logo

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

NCT06437054 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2026-05-22

No results posted yet for this study

Summary

This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing loss. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.

Conditions

  • Hearing Loss, Sensorineural
  • Hearing Loss, Sudden
  • Intratympanic Injection

Interventions

DRUG

Dexamethasone

Dexamethasone 5mg/ml

DRUG

Hyaluronic acid

Hyaluronic Acid 20mg/2ml

OTHER

Indocyanine green(ICG)

ICG 25mg

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-15
Primary Completion
2026-12-15
Completion
2028-09-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06437054 on ClinicalTrials.gov